Solvay SA (FRA:SOL)
Germany · Delayed Price · Currency is EUR 27.12
-0.20 (-0.73%)
Last updated: Aug 1, 2025
Intra-Cellular Therapies Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 4,368 | 4,540 | 4,880 | 5,539 | 10,105 | 8,965 | Upgrade |
Other Revenue | 586 | 590 | 1,145 | 2,440 | 1,329 | 749 | Upgrade |
| 4,954 | 5,130 | 6,025 | 7,979 | 11,434 | 9,714 | Upgrade | |
Revenue Growth (YoY) | -7.19% | -14.85% | -24.49% | -30.22% | 17.71% | -13.48% | Upgrade |
Cost of Revenue | 3,904 | 3,984 | 4,642 | 6,554 | 8,508 | 7,207 | Upgrade |
Gross Profit | 1,050 | 1,146 | 1,383 | 1,425 | 2,926 | 2,507 | Upgrade |
Selling, General & Admin | 456 | 441 | 526 | 565 | 1,233 | 1,212 | Upgrade |
Research & Development | 22 | 34 | 47 | 46 | 325 | 300 | Upgrade |
Other Operating Expenses | 84 | 97 | -10 | -310 | 157 | 134 | Upgrade |
Operating Expenses | 562 | 572 | 563 | 301 | 1,715 | 1,646 | Upgrade |
Operating Income | 488 | 574 | 820 | 1,124 | 1,211 | 861 | Upgrade |
Interest Expense | -100 | -107 | -65 | -43 | -99 | -112 | Upgrade |
Interest & Investment Income | 15 | 17 | 36 | 16 | 9 | 8 | Upgrade |
Earnings From Equity Investments | 35 | 38 | 53 | 153 | 158 | 58 | Upgrade |
Currency Exchange Gain (Loss) | -3 | -3 | 3 | 24 | - | -9 | Upgrade |
Other Non Operating Income (Expenses) | 9 | 24 | -74 | 23 | -5 | -76 | Upgrade |
EBT Excluding Unusual Items | 444 | 543 | 773 | 1,297 | 1,274 | 730 | Upgrade |
Merger & Restructuring Charges | -84 | -89 | -455 | -96 | -228 | -147 | Upgrade |
Impairment of Goodwill | - | - | -38 | - | - | -1,050 | Upgrade |
Gain (Loss) on Sale of Investments | -14 | -22 | 4 | - | 9 | -8 | Upgrade |
Gain (Loss) on Sale of Assets | 17 | 6 | 3 | 3 | 12 | 3 | Upgrade |
Asset Writedown | -34 | -45 | -57 | 37 | - | -351 | Upgrade |
Legal Settlements | -12.6 | -1 | -12 | - | 61 | -20 | Upgrade |
Other Unusual Items | -124.4 | -72 | -38 | -110 | -34 | -1 | Upgrade |
Pretax Income | 192 | 320 | 180 | 1,131 | 1,094 | -844 | Upgrade |
Income Tax Expense | 46 | 87 | 208 | 228 | 110 | 248 | Upgrade |
Earnings From Continuing Operations | 146 | 233 | -28 | 903 | 984 | -1,092 | Upgrade |
Earnings From Discontinued Operations | - | - | 2,130 | 1,016 | 5 | 163 | Upgrade |
Net Income to Company | 146 | 233 | 2,102 | 1,919 | 989 | -929 | Upgrade |
Minority Interest in Earnings | -7 | -10 | -9 | -14 | -41 | -33 | Upgrade |
Net Income | 139 | 223 | 2,093 | 1,905 | 948 | -962 | Upgrade |
Net Income to Common | 139 | 223 | 2,093 | 1,905 | 948 | -962 | Upgrade |
Net Income Growth | -92.38% | -89.34% | 9.87% | 100.95% | - | - | Upgrade |
Shares Outstanding (Basic) | 105 | 105 | 104 | 104 | 104 | 103 | Upgrade |
Shares Outstanding (Diluted) | 106 | 106 | 104 | 104 | 104 | 103 | Upgrade |
Shares Change (YoY) | 0.75% | 1.82% | 0.02% | 0.34% | 0.63% | -0.25% | Upgrade |
EPS (Basic) | 1.33 | 2.12 | 20.09 | 18.36 | 9.16 | -9.33 | Upgrade |
EPS (Diluted) | 1.31 | 2.10 | 20.09 | 18.30 | 9.14 | -9.33 | Upgrade |
EPS Growth | -92.49% | -89.55% | 9.80% | 100.26% | - | - | Upgrade |
Free Cash Flow | 259 | 343 | 944 | 1,191 | 938 | 788 | Upgrade |
Free Cash Flow Per Share | 2.45 | 3.23 | 9.06 | 11.44 | 9.04 | 7.64 | Upgrade |
Dividend Per Share | 1.460 | 2.430 | 2.430 | 4.050 | 3.850 | 3.750 | Upgrade |
Dividend Growth | -17.98% | - | -40.00% | 5.20% | 2.67% | - | Upgrade |
Gross Margin | 21.20% | 22.34% | 22.95% | 17.86% | 25.59% | 25.81% | Upgrade |
Operating Margin | 9.85% | 11.19% | 13.61% | 14.09% | 10.59% | 8.86% | Upgrade |
Profit Margin | 2.81% | 4.35% | 34.74% | 23.88% | 8.29% | -9.90% | Upgrade |
Free Cash Flow Margin | 5.23% | 6.69% | 15.67% | 14.93% | 8.20% | 8.11% | Upgrade |
EBITDA | 724 | 821 | 1,550 | 1,898 | 1,946 | 1,716 | Upgrade |
EBITDA Margin | 14.61% | 16.00% | 25.73% | 23.79% | 17.02% | 17.66% | Upgrade |
D&A For EBITDA | 236 | 247 | 730 | 774 | 735 | 855 | Upgrade |
EBIT | 488 | 574 | 820 | 1,124 | 1,211 | 861 | Upgrade |
EBIT Margin | 9.85% | 11.19% | 13.61% | 14.09% | 10.59% | 8.86% | Upgrade |
Effective Tax Rate | 23.96% | 27.19% | 115.56% | 20.16% | 10.05% | - | Upgrade |
Revenue as Reported | 4,955 | 5,130 | 6,024 | 7,979 | 11,434 | 9,714 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.